On the other hand, whether this new, FIG4-related genetic form of parkinsonism is a synucleinopathy, like typical sporadic PD, remains an open question, as no reported data on α-synuclein immunohistochemistry or seed amplification assays (SAA) in patients’ tissues or biological fluids have been provided. This evidence concerns the gene FIG4 and synucleinopathy.